Article Details
Retrieved on: 2023-01-09 21:23:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Thorne HealthTech (NASDAQ: THRN) had challenged the validity of the '086 patent at the U.S. Patent Trial and Appeal Board (PTAB), and the PTAB had ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here